Articles from Countdown
Funding supports pioneering research to evaluate a novel approach designed to restore cellular energy and preserve muscle function, laying the foundation for a new generation of therapies across rare disease, chronic disease, and aging
By Countdown · Via GlobeNewswire · July 29, 2026
ATLANTA, May 15, 2026 (GLOBE NEWSWIRE) -- Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr. Elias Adriaenssens at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.
By Countdown · Via GlobeNewswire · May 15, 2026
